Icra sees pharma industry growth tapering to 7-10% over FY18-FY20Post published:July 4, 2017Post category:Industry NewsThe Indian pharma industry is likely to witness a slowdown in growth because of pricing pressure and regulatory interventions in the US, according to an Icra report Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostIndoStar Capital close to acquiring ICICI Home Finance Next PostGST rates: Footwear to cost more as firms look to increase prices by 5-7% You Might Also Like The Digital Twin – Enabling Realtime Closed Loop Manufacturing Optimization September 18, 2019 Edge Computing, Time-Sensitive Networks and IIoT Interoperability from IIC Partnerships October 27, 2017 TM Robotics assists Toshiba Machine to launch THE400 SCARA robot January 3, 2018
Edge Computing, Time-Sensitive Networks and IIoT Interoperability from IIC Partnerships October 27, 2017